K01DA055521 (Q30784): Difference between revisions

@@ Property / instance of @@
+grant
@@ Property / instance of: grant / rank @@
+Normal rank
@@ Property / instance of: grant / reference @@
+stated in: PubMed
@@ Property / grant identifier @@
+K01 DA055521
@@ Property / grant identifier: K01 DA055521 / rank @@
+Normal rank
@@ Property / grant identifier: K01 DA055521 / reference @@
+stated in: PubMed
@@ Property / grant identifier @@
+K01DA055521
@@ Property / grant identifier: K01DA055521 / rank @@
+Normal rank
@@ Property / grant identifier: K01DA055521 / reference @@
+stated in: PubMed
@@ Property / NIH funding mechanism @@
+K series
@@ Property / NIH funding mechanism: K series / rank @@
+Normal rank
@@ Property / NIH funding mechanism: K series / reference @@
+stated in: PubMed
@@ Property / award type @@
+K01
@@ Property / award type: K01 / rank @@
+Normal rank
@@ Property / award type: K01 / reference @@
+stated in: PubMed
@@ Property / institute code @@
+DA
@@ Property / institute code: DA / rank @@
+Normal rank
@@ Property / institute code: DA / reference @@
+stated in: PubMed
@@ Property / serial number @@
@@ Property / serial number: 055521 / rank @@
+Normal rank
@@ Property / serial number: 055521 / reference @@
+stated in: PubMed
@@ Property / funder @@
+National Institute on Drug Abuse
@@ Property / funder: National Institute on Drug Abuse / rank @@
+Normal rank
@@ Property / funder: National Institute on Drug Abuse / reference @@
+stated in: PubMed
@@ Property / primary funding institute or center @@
+National Institute on Drug Abuse
+Normal rank
+stated in: PubMed
@@ Property / country of origin @@
+United States of America
@@ Property / country of origin: United States of America / rank @@
+Normal rank
@@ Property / country of origin: United States of America / reference @@
+stated in: PubMed

K01DA055521 (Q30784): Difference between revisions

Latest revision as of 18:07, 11 November 2024

Statements

Navigation menu

Search